News September 7, 2022 Inherent Biosciences raises Series A funding led by Propel Bio Partners May 12, 2022 Inherent Biosciences Announces Podium Presentations at American Urological Association Annual Meeting 2022 April 13, 2021 Inherent Biosciences Awarded NIH SBIR Phase I Grant to commercialize innovative diagnosis of non-obstructive azoospermia October 18, 2021 Inherent Biosciences launches Path Fertility – Epigenetic Sperm Quality Test (SpermQT) February 17, 2021 Inherent Biosciences Raises Seed Round, adds Board Members and Clinical Advisors September 9, 2020 Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response
